These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15902647)

  • 21. [PSA: a new prostatic marker. A help or an added factor of confusion?].
    Huber PR; Wisard M; Schmid HP
    Ann Urol (Paris); 1994; 28(4):235-7. PubMed ID: 7526773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is digital screening for prostatic cancer effective?
    Louria DB
    Bull N Y Acad Med; 1992 Nov; 68(4):470-5. PubMed ID: 1283361
    [No Abstract]   [Full Text] [Related]  

  • 23. [Early diagnosis of cancer of the prostate. 5-year analysis].
    Sanz Velez JI; Allepuz Losa C; Gil Sanz MJ; Plaza L; Castrillo J; Cuesta Presedo JM; Rioja Sanz LA
    Actas Urol Esp; 1997 Oct; 21(9):827-34. PubMed ID: 9471865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of rectal exploration, suprapubic and transrectal prostatic ultrasonography, and PSA in the diagnosis and follow-up of prostatic carcinoma].
    Speranza I; Bianco V; Banci M; Muià R; Gianni W; Bacciu O; Vecchione A; Marchei P
    Minerva Med; 1998; 89(7-8):267-75. PubMed ID: 9824988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MRI for troubleshooting detection of prostate cancer].
    Beyersdorff D; Hamm B
    Rofo; 2005 Jun; 177(6):788-95. PubMed ID: 15902626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validity of transrectal ultrasonography and echo-guided biopsy in the early diagnosis of prostatic neoplasms. Our experience on 100 cases].
    Mantelli M; Iacono R; Quattropanetti S; Quattropanetti R; Begani Provinciali R
    Arch Ital Urol Androl; 1993 Aug; 65(4):413-5. PubMed ID: 7689015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels].
    Kihara T; Ito F; Kobayashi C; Ryoji O; Tokumoto T; Iguchi Y; Maeda Y; Onizuka S; Goya N; Nakazawa H; Toma H
    Hinyokika Kiyo; 1997 Jan; 43(1):13-8. PubMed ID: 9046415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urological diagnosis of prostate carcinoma].
    Müller-Lisse UL; Hofstetter A
    Radiologe; 2003 Jun; 43(6):432-40. PubMed ID: 12827257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The 10-minute consultation. With weak discharge often past the target...].
    Hofstetter A
    MMW Fortschr Med; 2004 Nov; 146(45):67-8. PubMed ID: 15581113
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of prostate specific antigen acceleration for prostate cancer diagnosis.
    Benecchi L; Pieri AM; Pastizzaro CD; Potenzoni M
    J Urol; 2011 Mar; 185(3):821-6. PubMed ID: 21238998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal cancer of the breast: diagnosis by mammography.
    Asaro JR
    W V Med J; 1977 Feb; 73(2):25-8. PubMed ID: 264712
    [No Abstract]   [Full Text] [Related]  

  • 32. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
    Pushkar' DIu; Rasner PI; Skobelev PP
    Urologiia; 2001; (6):48-54. PubMed ID: 11785083
    [No Abstract]   [Full Text] [Related]  

  • 33. Staging prostate cancer.
    Levy DA; Resnick MI
    Compr Ther; 1994; 20(12):665-8. PubMed ID: 7533688
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and histopathological characteristics of nonpalpable prostatic carcinoma].
    Landmann C
    Strahlenther Onkol; 1995 Mar; 171(3):174-5. PubMed ID: 7535953
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of methods of detection for prostate neoplasm].
    Zhong C; Chen M; Wan B
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):64-6. PubMed ID: 11783074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.
    Casciani E; Polettini E; Bertini L; Emiliozzi P; Amini M; Pansadoro V; Gualdi GF
    Radiol Med; 2004; 108(5-6):530-41. PubMed ID: 15722999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of various examination methods in the management of prostatic cancer].
    Romics I; Kaldenbach R; Bach D
    Orv Hetil; 1994 May; 135(22):1191-4. PubMed ID: 7517027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The correlation between the level of prostate-specific antigen and prostate gland volume in the early diagnosis of prostatic cancer].
    Billebaud T; Astier L; Villers A; Boccon-Gibod L; Dauge MC; Sibert A; Baron JC; Delmas V; Boccon-Gibod L
    Prog Urol; 1991 Feb; 1(1):124-31. PubMed ID: 1285391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer and prostate specific antigen. A Jamaican perspective.
    Douglas LL
    West Indian Med J; 1999 Jun; 48(2):47-9. PubMed ID: 10492600
    [No Abstract]   [Full Text] [Related]  

  • 40. To color Doppler image the prostate or not: that is the question.
    Alexander AA
    Radiology; 1995 Apr; 195(1):11-3. PubMed ID: 7534428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.